Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study.

Ghosh N, Eyre TA, Brown JR, Lamanna N, Manzoor BS, Coombs CC, Tuncer HH, Ujjani C, Leslie LA, Roeker LE, Davids MS, Rhodes JM, Skarbnik AP, Sinai W, Fleury I, Hill BT, Martinez-Calle N, Barr PM, Jawaid D, Emechebe N, Pearson L, Lansigan F, Choi Y, Jensen CE, Fakhri B, Stephens DM, Marx SE, Schuster SJ, Coyle M, Pivneva I, Watson T, Guerin A, Shadman M

Open source

DOI: 10.1002/ajh.27563
Published: 2025 Mar
Container: American journal of hematology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ajh.27563,
  title = {Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study.},
  author = {Ghosh N and Eyre TA and Brown JR and Lamanna N and Manzoor BS and Coombs CC and Tuncer HH and Ujjani C and Leslie LA and Roeker LE and Davids MS and Rhodes JM and Skarbnik AP and Sinai W and Fleury I and Hill BT and Martinez-Calle N and Barr PM and Jawaid D and Emechebe N and Pearson L and Lansigan F and Choi Y and Jensen CE and Fakhri B and Stephens DM and Marx SE and Schuster SJ and Coyle M and Pivneva I and Watson T and Guerin A and Shadman M},
  year = {2025},
  journal = {American journal of hematology},
  doi = {10.1002/ajh.27563},
  url = {https://doi.org/10.1002/ajh.27563}
}

RIS

TY  - JOUR
TI  - Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study.
AU  - Ghosh N
AU  - Eyre TA
AU  - Brown JR
AU  - Lamanna N
AU  - Manzoor BS
AU  - Coombs CC
AU  - Tuncer HH
AU  - Ujjani C
AU  - Leslie LA
AU  - Roeker LE
AU  - Davids MS
AU  - Rhodes JM
AU  - Skarbnik AP
AU  - Sinai W
AU  - Fleury I
AU  - Hill BT
AU  - Martinez-Calle N
AU  - Barr PM
AU  - Jawaid D
AU  - Emechebe N
AU  - Pearson L
AU  - Lansigan F
AU  - Choi Y
AU  - Jensen CE
AU  - Fakhri B
AU  - Stephens DM
AU  - Marx SE
AU  - Schuster SJ
AU  - Coyle M
AU  - Pivneva I
AU  - Watson T
AU  - Guerin A
AU  - Shadman M
PY  - 2025
JO  - American journal of hematology
DO  - 10.1002/ajh.27563
UR  - https://doi.org/10.1002/ajh.27563
ER  -

APA

N, G., TA, E., JR, B., N, L., BS, M., CC, C., HH, T., C, U., LA, L., LE, R., MS, D., JM, R., AP, S., W, S., I, F., BT, H., N, M., PM, B., D, J., N, E., L, P., F, L., Y, C., CE, J., B, F., DM, S., SE, M., SJ, S., M, C., I, P., T, W., A, G., & M, S. (2025). Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study.. American journal of hematology. https://doi.org/10.1002/ajh.27563

Source records

pubmed · retrieved 2026-09-26T18:13:24.587Z